EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 2
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Volume 14 Issue 6

Taking a Long-Term Approach to Improving Vaccine Trial Recruitment

The groundbreaking mRNA technology used in the COVID-19 vaccine has potential applications in preventing a number of other infectious diseases and is ushering in a wa...
30 November 2022 Volume 14 Issue 6 cost | COVID
Continue Reading →
Regional News

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come. Germany will pay u...
17 March 2022 Regional News BioNTech | CureVac
Continue Reading →
Regional News

Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completion

Samsung Biologics has been on an expansion sprint, with plans to speedily complete a so-called Super Plant already giving way to designs on follow-up facilities in th...
26 January 2022 Regional News biologics | mRNA
Continue Reading →
Regional News

Ginkgo and Aldevron tout mRNA manufacturing ‘breakthrough’—and the perks could stretch well beyond COVID-19, exec says

A multibillion-dollar SPAC deal? Check. An international acquisition? Check. An mRNA vaccine production "breakthrough?" Ginkgo Bioworks says it has that, too. With i...
10 August 2021 Regional News manufacturing | Moderna
Continue Reading →
Regional News

BioNTech, eyeing $18B-plus in COVID-19 vaccine sales this year, poised to join the ranks of the world’s top drugmakers

The COVID-19 pandemic helped put mRNA vaccines on the map. Now, thanks to the shots' quick uptake in rich countries, mRNA specialist BioNTech appears poised to join t...
10 August 2021 Regional News BioNTech | coronavirus
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte